INVIVYD INC (IVVD) Fundamental Analysis & Valuation
NASDAQ:IVVD • US00534A1025
Current stock price
1.3 USD
+0.11 (+9.24%)
At close:
1.32 USD
+0.02 (+1.54%)
After Hours:
This IVVD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IVVD Profitability Analysis
1.1 Basic Checks
- IVVD had negative earnings in the past year.
- IVVD had a negative operating cash flow in the past year.
- IVVD had negative earnings in each of the past 5 years.
- In the past 5 years IVVD always reported negative operating cash flow.
1.2 Ratios
- IVVD has a better Return On Assets (-18.96%) than 77.18% of its industry peers.
- IVVD's Return On Equity of -21.73% is amongst the best of the industry. IVVD outperforms 80.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.96% | ||
| ROE | -21.73% | ||
| ROIC | N/A |
ROA(3y)-78.94%
ROA(5y)-67.28%
ROE(3y)-128.42%
ROE(5y)-98.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 92.99%, IVVD belongs to the best of the industry, outperforming 93.62% of the companies in the same industry.
- IVVD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 92.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. IVVD Health Analysis
2.1 Basic Checks
- IVVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- IVVD has more shares outstanding than it did 1 year ago.
- IVVD has more shares outstanding than it did 5 years ago.
- IVVD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IVVD has an Altman-Z score of 1.87. This is not the best score and indicates that IVVD is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of IVVD (1.87) is better than 64.99% of its industry peers.
- IVVD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.87 |
ROIC/WACCN/A
WACC9.29%
2.3 Liquidity
- IVVD has a Current Ratio of 7.24. This indicates that IVVD is financially healthy and has no problem in meeting its short term obligations.
- IVVD's Current ratio of 7.24 is fine compared to the rest of the industry. IVVD outperforms 68.09% of its industry peers.
- A Quick Ratio of 7.24 indicates that IVVD has no problem at all paying its short term obligations.
- IVVD has a Quick ratio of 7.24. This is in the better half of the industry: IVVD outperforms 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.24 | ||
| Quick Ratio | 7.24 |
3. IVVD Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 75.84% over the past year.
- Looking at the last year, IVVD shows a very strong growth in Revenue. The Revenue has grown by 110.47%.
EPS 1Y (TTM)75.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)110.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.51%
3.2 Future
- Based on estimates for the next years, IVVD will show a very strong growth in Earnings Per Share. The EPS will grow by 29.91% on average per year.
- Based on estimates for the next years, IVVD will show a very strong growth in Revenue. The Revenue will grow by 60.86% on average per year.
EPS Next Y34.83%
EPS Next 2Y20.61%
EPS Next 3Y25.69%
EPS Next 5Y29.91%
Revenue Next Year157.24%
Revenue Next 2Y77.7%
Revenue Next 3Y74.33%
Revenue Next 5Y60.86%
3.3 Evolution
4. IVVD Valuation Analysis
4.1 Price/Earnings Ratio
- IVVD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year IVVD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- IVVD's earnings are expected to grow with 25.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3Y25.69%
5. IVVD Dividend Analysis
5.1 Amount
- IVVD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IVVD Fundamentals: All Metrics, Ratios and Statistics
1.3
+0.11 (+9.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)01-08 2026-01-08/bmo
Earnings (Next)05-13 2026-05-13
Inst Owners84.26%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change1.72%
Market Cap367.37M
Revenue(TTM)53.43M
Net Income(TTM)-52.49M
Analysts82
Price Target8.16 (527.69%)
Short Float %10.73%
Short Ratio8.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.83%
Min EPS beat(2)26.47%
Max EPS beat(2)55.18%
EPS beat(4)2
Avg EPS beat(4)-170.03%
Min EPS beat(4)-404.27%
Max EPS beat(4)55.18%
EPS beat(8)4
Avg EPS beat(8)-88.9%
EPS beat(12)5
Avg EPS beat(12)-64%
EPS beat(16)8
Avg EPS beat(16)-44.12%
Revenue beat(2)1
Avg Revenue beat(2)8.42%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)18.59%
Revenue beat(4)1
Avg Revenue beat(4)-25.27%
Min Revenue beat(4)-67.83%
Max Revenue beat(4)18.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.09%
EPS NQ rev (1m)35.3%
EPS NQ rev (3m)35.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-15%
Revenue NQ rev (1m)6.49%
Revenue NQ rev (3m)6.49%
Revenue NY rev (1m)1.72%
Revenue NY rev (3m)-5.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.88 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.52 | ||
| P/tB | 1.52 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.19
BVpS0.85
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.96% | ||
| ROE | -21.73% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 92.99% | ||
| FCFM | N/A |
ROA(3y)-78.94%
ROA(5y)-67.28%
ROE(3y)-128.42%
ROE(5y)-98.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 20.53% | ||
| Cap/Sales | 0.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.24 | ||
| Quick Ratio | 7.24 | ||
| Altman-Z | 1.87 |
F-Score3
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)52.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y34.83%
EPS Next 2Y20.61%
EPS Next 3Y25.69%
EPS Next 5Y29.91%
Revenue 1Y (TTM)110.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.51%
Revenue Next Year157.24%
Revenue Next 2Y77.7%
Revenue Next 3Y74.33%
Revenue Next 5Y60.86%
EBIT growth 1Y68.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-38.05%
EBIT Next 3Y50.79%
EBIT Next 5Y54.26%
FCF growth 1Y65.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.9%
OCF growth 3YN/A
OCF growth 5YN/A
INVIVYD INC / IVVD Fundamental Analysis FAQ
What is the fundamental rating for IVVD stock?
ChartMill assigns a fundamental rating of 4 / 10 to IVVD.
What is the valuation status for IVVD stock?
ChartMill assigns a valuation rating of 1 / 10 to INVIVYD INC (IVVD). This can be considered as Overvalued.
Can you provide the profitability details for INVIVYD INC?
INVIVYD INC (IVVD) has a profitability rating of 2 / 10.
What is the financial health of INVIVYD INC (IVVD) stock?
The financial health rating of INVIVYD INC (IVVD) is 7 / 10.
What is the expected EPS growth for INVIVYD INC (IVVD) stock?
The Earnings per Share (EPS) of INVIVYD INC (IVVD) is expected to grow by 34.83% in the next year.